Drugs / W0101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03316638 | Nov 2017 → Oct 2021 | — | Pierre Fabre Laboratories | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | W0101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03316638 ↗ |
| Route | Intravenous | “Intravenous Infusion of W0101” NCT03316638 ↗ |